Usability, acceptability, feasibility and cost of continuous glucose monitoring devices for diabetes in Kenya (ACCEDE U)

Mixed-methods prospective study on the usability, feasibility, acceptability, and cost of the use of continuous glucose monitoring devices among people living with type 1 diabetes in Kenya (ACCEDE U)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202505779463576

Enrollment

Registered

2025-05-14

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Continuous Glucose Monitoring device

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants are eligible to be included in the Study only if all of the following inclusion criteria apply. Individuals: • Being diagnosed with type 1 diabetes • 4 years and above • capacity to assent (7-17 years) and to consent (18 years and above).

Exclusion criteria

Exclusion criteria: Participants are excluded from the study if any of the following exclusion criteria apply. Individuals who: • younger than 4 years of age. • do not provide informed consent.

Design outcomes

Primary

Measure	Time frame
System Usability Scale SUS scores regarding the CGM from recipients of care. Perceptions on usability from qualitative discussions with recipients of care	—

Secondary

Measure	Time frame
SUS scores regarding the CGM and use of CGM data from health care workers involved in providing clinical care to people living with T1D. Perceptions on usability from qualitative discussions with HCWs.;Distribution of acceptability questionnaire scores. Perceptions on acceptability from qualitative discussions with HCWs, recipients of care and caregivers.	—

Countries

Kenya

Contacts

Public ContactEmmaculate Nzove

Program Manager at Kenyatta National Hospital

emukenyi@uw.edu+254725066676

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026